baber/WOPTO huggingface dataset:
Patent CA-2513853-A1 (CA)
Title: Indexation a base de syntagmes dans un systeme d'extraction d'information
Inventor: PATTERSON ANNA LYNN
IPC: G06F40/00
Filed: 2005-07-26
Abstract: Une méthode d'indexation de documents dans une collection de documents, chaque document possédant un identifiant, la méthode comprenant a) de fournir une liste de phrases, b) de trouver, par opération d'un processeur adapté pour la manipulation de données dans un système informatique, pour un document donné, des phrases de la liste de phrases qui sont présentes dans le document, c) de trouver, pour chaque phrase trouvée dans le document, par une opération d'un processeur adapté à la manipulation de données dans un système informatique, une phrase connexe également présente dans le document où, pour chaque phrase g j, g k est une phrase connexe de la phrase g j, où un gain d'information I de g k, par rapport à g j, excède un seuil prédéterminé, le gain d'information I étant une fonction de A(j,k) et E(j,k), où A(j,k) est une mesure d'un taux réel de cooccurrences de g j et g k, et E(j,k) est un taux escompté de cooccurrences de g j et g k, et d) d'indexer, par l'opération d'un processeur adapté à la manipulation de données dans un système informatique, le document en consignant l'identifiant de document et une indication de chaque phrase connexe g k également présente dans le document, dans une liste affichée de la phrase g j trouvée.
Patent CA-2514650-A1 (CA)
Inventor: GROTHER LEON PAUL
IPC: A61K9/22
Filed: 2004-02-09
Abstract: In order to reduce the disintegration time of solid, oral, fast-dispersing, lyophilized, pharmaceutical dosage forms, an edible acid such as citric acid is included in a composition used to produce said dosage forms where there is a pharmaceutically active ingredient having a low water solubility.
Patent CA-2514667-A1 (CA)
Title: Adjuvanted influenza vaccine
Inventor: O'HAGAN DEREK
IPC: A61K39/145
Filed: 2004-01-29
Abstract: The invention relates to compositions comprising one or more influenza antigens, one or more detoxified ADP-ribosylating proteins, and one or more chitosans. The invention also relates to methods of using these compositions to generate an immune response to influenza.
Patent CA-2516142-A1 (CA)
Title: Compositions comprising fatty acids and amino acids
Inventor: BEER MICHAEL
IPC: A23L1/30
Filed: 2004-02-23
Abstract: The invention relates to a combination, such as a combined preparation or pharmaceutical or nutritional composition, respectively, which comprises at least one cis-polyunsaturated fatty acid, at least one amino acid, and optionally at least one diabetes medicine for simultaneous, separate or sequential use in the prevention, delay of progression or treatment of diseases, especially metabolic disorders and in particular type 2 diabetes and diseases and conditions associated with diabetes.
Patent CA-2516265-A1 (CA)
Title: Use of r-10-hydroxy-10, 11-dihydro-carbamazepine in neuropathic pain
Inventor: BEVAN STUART
IPC: A61P25/02
Filed: 2004-02-16
Abstract: The present invention relates to the use of a mixture of the enantiomers of a compound of Formula (I) or of pharmaceutically acceptable salts of said enantiomers consisting of at least 55% of the R-enantiomer, most preferably of at least 98 % of the R-enantiomer, and not more than 45 % of the S-enantiomer, most preferably not more than 2 % of the Senantiomer, for the manufacture of a pharmaceutical composition for the treatment of neuropathic pain; to a method for the treatment of neuropathic pain; and to a pharmaceutical composition comprising as active agent a mixture of the enantiomers of the compound of formula I or pharmaceutically acceptable salts of said enantiomers consisting of at least 55 % of the R-enantiomer and not more than 45 % of the S-enantiomer.
Patent CA-2517782-A1 (CA)
Title: Improved bioavailability and improved delivery of alkaline pharmaceutical drugs
Inventor: YU RUEY J
IPC: A61K8/41
Filed: 2004-03-05
Abstract: Embodiments of the invention relate to a composition, a process of making the composition, and to the use of the composition. The compositions include a molecular complex formed between an alkaline pharmaceutical drug and at least one selected from a hydroxyacid, a polyhydroxy acid, a related acid, a lactone, or combinations thereof. The compositions provide improved bioavailability and improved delivery of the drug into the cutaneous tissues.
Patent CA-2518776-A1 (CA)
Title: Insulin analogs having protracted time action
Inventor: ZHANG LIANSHAN
IPC: A61K38/00
Filed: 2004-04-22
Abstract: The present invention provides the insulin analog A0Arg A21Gly B31Arg B32Arg, which provides a protracted, even basal duration of action. The present invention also provides a method of treating diabetes mellitus comprising administering the insulin analog.
Patent CA-2521976-A1 (CA)
Title: Electrical outlet box having attachable walls
Inventor: MICHAUD ALAIN
IPC: H02G3/08
Filed: 2005-09-29
Abstract: An electrical outlet box including a first planar box wall and a second planar box wall. The first and second box walls are positioned substantially perpendicular to each other.  One of the walls includes an extending clip. The other wall includes a receiving slot. The clip is insertable into the slot to couple the first box wall to the second box wall.
Patent CA-2522132-A1 (CA)
Inventor: SUZUKI RYUICHI
IPC: C02F1/68
Filed: 2005-03-08
Abstract: The present invention relates to water modifier for improvement in the characteristics of water and has been made such as for improvement of the fuel consumption of an automobile or giving a good function to the human body, based on a new conception of modifying water itself, which water is capable of being associated with the combustion efficiency, such as water stored in a radiator or water in the form of water vapor contained in air which is mixed with gasoline for combustion, without the necessity to modify an engine or electric system or the necessity to add something to lubricant or the like. It is an object of the present invention to provide water modifier that is capable of contributing to the improvement of fuel consumption of an automobile and giving a function, which desirably affects to the human body, to water, by modifying water per se.  Water modifier according to the present invention includes fired earthy substance that contains at least one of Al2O3, B2O3, BaO, CaO, Fe2O3, K2O, MgO, MnO, Na2O, SiO2, TiO2 and ZnO.
Patent CA-2522449-A1 (CA)
Title: Method and apparatus for focusing an rfid reader to avoid signal collisions of closely spaced rfid tags
Inventor: DERTADIAN SAAK
IPC: H01Q3/26
Filed: 2005-10-06
Abstract: A reader for radio frequency identification tags, and a method for narrowing the electromagnetic field of tags passing before the reader, the reader having: at least one main antenna emitting an electro-magnetic field; counter coil antennas located adjacent to said at least one main antenna, each the at least one main antenna being disposed between two of the counter coil antennas, the counter coil antennas emitting an electromagnetic field opposite in polarity to the electro-magnetic field of the main antenna, wherein the configuration of the at least one main antenna and the counter coil antennas narrows an enabling electromagnetic field experienced by radio frequency identification tags in front of the reader. Multiple readers are possible with synchronization of the clocks of the readers to avoid interference.
Patent CA-2523436-A1 (CA)
Inventor: COX BRIAN
IPC: C07D519/00
Filed: 2004-04-30
Abstract: Compounds of formula (I), in salt or zwitterionic form wherein, wherein R1, R2, R3, and R4 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by the muscarinic M3 receptor.  Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
Patent CA-2525839-A1 (CA)
Title: Crystalline form of .beta.2 adrenergic receptor agonist
Inventor: HUBBARD CRISTIN
IPC: C07C233/43
Filed: 2004-05-26
Abstract: The invention provides a novel .beta.2 adrenergic receptor agonist in crystalline salt form. The invention also provides pharmaceutical compositions comprising the novel .beta.2 adrenergic receptor agonist in crystalline salt form, formulations containing the pharmaceutical compositions, methods of using the crystalline salt to treat diseases associated with .beta.2adrenergic receptor activity, and processes useful for preparing such crystalline compounds.
Patent CA-2529103-A1 (CA)
Inventor: WATKINS LINDA MAY ROTHBLUM
IPC: C07H21/02
Filed: 2004-05-28
Abstract: Methods of treating pain by delivery of anti-inflammatory cytokines, proinflammatory cytokine antagonists, and agents that act to reduce or preve nt proinflammatory cytokine actions, to the nervous system are described. These agents can be delivered using gene therapy techniques. Alternatively, the agents can be delivered in protein compositions.
Patent CA-2534852-A1 (CA)
Title: Novel catalysts for selective isocyanate dimerisation
Inventor: KOECHER JUERGEN
IPC: C08G18/16
Filed: 2004-07-26
Abstract: The invention relates to the use of sulphonamide anions as dimerisation catalysts for isocyanates and a method for the production of oligomeric isocyanates using said catalysts.
Patent CA-2535796-A1 (CA)
Title: N-aryl-2-cyanooxazolidinones and their derivatives
Inventor: OCHOADA JASON MATTHEW
IPC: A61K31/422
Filed: 2004-08-09
Abstract: The present invention provides antibacterial agents having the formulae (I) and (II) as described herein.
Patent CA-2536453-A1 (CA)
Title: Use of surfactant preparations for the treatment of surgical adhesions
Inventor: AMMON EVA
IPC: A61K9/12
Filed: 2004-08-27
Abstract: The invention describes the use of surfactant comprising phospholipids and pulmonary surfactant proteins for the treatment of surgical adhesions.
Patent CA-2540164-A1 (CA)
Title: Guide to align bone anchors
Inventor: JUSTIS JEFF R
IPC: A61B17/00
Filed: 2004-09-22
Abstract: Instruments and methods include a guide instrument (100, 220) mountable to at least one anchor extension (40) to guide the positioning of an anchor (10) in a bony segment. The guide instrument (100, 220) facilitates aligning the anchor (10) with one or more other anchors (10) already engaged to the bony segment. The anchors (10) can then be engaged with a connecting element (90) extending therebetween. The guide instrument (100, 220) facilitates multi-level fixation of bony segments with bone anchors (10) and one or more connecting elements (90) in a minimally invasive surgical approach.
Patent CA-2542192-A1 (CA)
Title: Look-through mutagenesis
Inventor: CREA ROBERTO
IPC: C07K16/12
Filed: 2004-06-25
Abstract: A method of mutagenesis by which a predetermined amino acid is introduced in to each and every position of a selected set of positions in a preselected regi on (or several different regions) of a polypeptide to produce a library of polypeptide analogs. The method is based on the premise that certain amino acids play crucial role in the structure and function of proteins. Libraries can be generated which contain only desired polypeptide analogs and are of reasonable size for screening. The libraries can be used to study the role o f specific amino acids in polypeptide structure and function and to develop ne w or improved polypeptides such as antibodies, antibody fragments, single chai n antibodies, enzymes, and ligands.
Patent CA-2543350-A1 (CA)
Title: Films disintegrables destines a des dispositifs de diagnostic
Inventor: BARNHART SCOTT D
IPC: A61K31/716
Filed: 2004-10-22
Abstract: L'invention concerne des compositions de films désintégrables destinées à des dispositifs de test de diagnostic. Ces films sont préparés à l'aide d'une combinaison de composants qui produisent des films à résistance suffisante et à profils de désintégration souhaitée. Un film désintégrable de l'invention contient un composant à poids moléculaire élevé soluble dans l'eau, un composant à poids moléculaire bas soluble dans l'eau et un ou plusieurs réactifs destinés à être utilisés dans un dispositif de diagnostic. Ces films peuvent éventuellement contenir un composant amylacé, un composant glucosé, un plastifiant et/ou un humectant, et/ou un remplisseur. L'invention concerne, en outre, un dispositif de test de diagnostic qui comprend un film de l'invention, et des procédés d'utilisation de ces dispositifs.
Patent CA-2543798-A1 (CA)
Title: Pneumatic two-dimensional structure
Inventor: PEDRETTI MAURO
IPC: E04B7/08
Filed: 2004-11-01
Abstract: The invention relates to a pneumatic plate element (1) consisting of a hollow body (3) that can be impinged upon with a pressure medium having overpressure p. Said hollow body is located between two pressure/tension elements (2) that are connected to one another by their ends and is made of a flexible membrane (9). When transversal load is exerted on the plate element (1) placed on two supports (17) with load force F, the top pressure/tension element (2, 7) is subjected to pressure and the bottom pressure/tension element (2, 8) is subjected to tension. Prestressed tension elements (4) placed at a distance a traverse in channels the hollow body (3) between the pressure/tension elements (2, 8). The tension elements (4) are prestressed by the hollow body (3) separating the tension elements (2). The connections (6) operate as fictitious fixed intermediate supports and stabilize the pressure/tension element (2, 7) submitted to pressure in order to prevent buckling. Two-dimensional plate elements (1) can be particularly used for building roofs of lightweight constructions.
Patent CA-2544145-A1 (CA)
Title: Composition and method for treating macular degeneration
Inventor: ZELDIS JEROME B
IPC: A61K31/56
Filed: 2004-04-28
Abstract: Methods of treating, preventing and/or managing macular degeneration are disclosed. Specific embodiments encompass the administration of an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent and/or surgery. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Patent CA-2545089-A1 (CA)
Inventor: NOBLE JOHN M
IPC: C10M141/06
Filed: 2004-10-29
Abstract: A water-based, recyclable metalworking fluid comprises a polyalkylene glycol, an alkanolamine, a polyglycol surfactant, a polyol surfactant, a biocide and a corrosion inhibitor. The biocide may comprise a mixture of biocidal compounds effective against bacterial and fungal organisms. The material may also include an isoalkoxy amine oxide and a glycol ether. The composition may also include ancillary ingredients such as viscosity controlling agents, defoamers, coloring agents and the like. It is a notable feature of the composition of the present invention that it is free of hazardous materials and fatty acids.  Also disclosed is a method for using the composition in a metal-shaping operation.
Patent CA-2545255-A1 (CA)
Inventor: PRESTA LEONARD G
IPC: C07K16/24
Filed: 2004-11-09
Abstract: The methods and compositions provided herein relate generally to IL-10 specific antibodies and uses thereof. More specifically, compositions of humanized IL-10 specific antibodies and methods to use such antibodies in modulating the biological activity of IL-10, particularly in autoimmune disorders and pathogen-mediated immunopathology.
Patent CA-2549354-A1 (CA)
Title: Process for preparing raloxifene hydrochloride
Inventor: ZINETTI FABRIZIO
IPC: C07D333/56
Filed: 2004-06-28
Abstract: Process for preparing raloxifene hydrochloride with a purity greater than 98%  and low aluminium content comprising the following stages a) demethylation of 6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophene in pyridine and hydrochloric acid to obtain 6-hydroxy~2-(4-hydroxyphenyl)benzo[b]thiophene in pyridine hydrochloride, b) acetylation of 6-hydroxy-2-(4~hydroxyphonyl)benzo[b]thiophene with an acetylating agent to obtain the corresponding 6-acetoxy-2-(4 acetoxyphenyl)benzo[b]thiophene, c) acylation of 6-acetoxy-2-(4-acetoxyphonyl)benzo[b]thlophene with 4-(2 piperidinoethoxy)benzoylchloride hydrochloride with aluminium trichloride in halogenated solvent to obtain 6-acetoxy-2-(4~acetoxyphenyl)-3-[4-(2 piperidinoethoxy)benzoyl]-benzo[b]thiophene, d) hydrolysis of 6-acetoxy-2-(4-acetoxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyll benzo[b]thiophene according to the following operating conditions: dl) treatment of 6-acetoxy-2-(4-acetoxyphonyl)-3-[4-(2~piperidinoethoxy)benzoyl]benzo[b]thiophene with alkaline hydroxide in alcohol solvent, d2) acidification of the product obtained in the preceding stage (dl) with a strong acid, to obtain the corresponding raloxifene salt with the strong acid, characterised in that the strong acid used in stage (d2) is concentrated hydrochloric acid.
Patent CA-2551140-A1 (CA)
Title: Pressure actuated safety valve with spiral flow membrane
Inventor: WEAVER KARLA
IPC: A61M25/00
Filed: 2005-01-12
Abstract: A pressure activated valve comprises a valve housing defining a lumen for receiving bodily fluids therein and a flexible membrane disposed in the valve housing. The flexible membrane includes a slit extending therethrough so that the flexible membrane may be moved between an open and a closed configuration based on fluid pressure within the lumen. A nonthrombogenic coating may be formed on fluid contacting surfaces of the flexible membrane.
Patent CA-2551996-A1 (CA)
Inventor: CLARKE LUCAS LEMAR
IPC: G01T1/20
Filed: 2006-06-22
Abstract: A scintillator composition includes a matrix material, where the matrix material includes an alkaline earth metal and a lanthanide halide. The scintillator composition further includes an activator ion, where the activator ion is a trivalent ion.  In one embodiment, the scintillator composition includes a matrix material represented by A2LnX7, where A includes an alkaline earth metal, Ln includes a lanthanide ion, and X includes a halide ion. In another embodiment, the scintillator composition includes a matrix material represented by ALnX5, where A includes an alkaline earth metal, Ln includes a lanthanide ion, and X includes a halide ion. In these embodiments, the scintillator composition includes an activator ion, where the activator ion includes cerium, or bismuth, or praseodymium, or combinations thereof.
Patent CA-2552647-A1 (CA)
Inventor: RUST RANCE S
IPC: H01R24/58
Filed: 2005-01-07
Abstract: A connector (11) for a communications system provides desired levels of crosstalk by controlling the positions and lengths of the wires. The connector (11) has an internal chamber opening on the rear end (23) of the plug housing and defined by housing walls. A plurality of slots (31) extend through one of the housing walls adjacent its front end (22) and into the internal chamber (24). A plurality of insulation displacement contacts (41) is movement in the slots (31) for movement between retracted positions and inserted positions extending into the internal chamber (24). A first insert (51) is disposed in the internal chamber (24). The first insert (51) has a front end (22) proximal the front end (22) of the plug housing (21). A first passageway (53) extends from the front end (52) of the first insert (51) to the rear end (54) of the first insert (51). A plurality of openings in a first insert wall adjacent the front end are aligned with the plurality of slots (31) in the plug housing (21) and extend into the first passageway (53). A second insert (61) is partially disposed in the internal chamber (24) and has a front end (61) proximal the first insert rear end (54). The second insert (61) has first, second, third and fourth channels (65-68) extending from the front end (62) the rear end (63) of the second insert (61). Four pairs of wires extend from a cable sheath (72). Each pair of wires pass through one of the first, second, third and fourth channels (64-67) of the second insert (61) and through the first passageway (53) to the insulation displacement contacts (41) in the internal chamber (24).
Patent CA-2552690-A1 (CA)
Title: Administration par voie transdermique utilisant un agent encapsule active par les ultrasons et/ou la chaleur
Inventor: WEIMANN LUDWIG J
IPC: A61L15/16
Filed: 2003-12-31
Abstract: L'invention concerne une méthode d'administration d'une substance à travers au moins une couche dermique. La méthode consiste à: administrer une substance contenue dans des microcapsules de taille préétablie placées dans un support (150); placer le support contenant les microcapsules sur une surface d'une bande adhésive (100) adjacente à la peau (320) d'un humain ou d'un animal; et appliquer sur la bande adhésive une énergie (200) ayant la propriété de perturber l'intégrité des microcapsules, ce qui entraîne la libération de la substance des microcapsules. Cette énergie peut être appliquée sélectivement pour libérer la substance à des moments désirés, ladite substance pouvant être un médicament ou un autre principe actif.
Patent CA-2553486-A1 (CA)
Inventor: DINEL DARRYL
IPC: A01K1/035
Filed: 2005-01-12
Abstract: The automated cage cleaning system is comprised of a pair of robotic arms, a soil side robot and a clean side robot. The soil side robot is utilized for removing the dirty cage bottoms from a cart, rack, pallet, or fixture, emptying soiled bedding from the cage bottoms, and placing the cage bottoms on a conveyer leading to the tunnel washing equipment. The clean side robot is used to grip the clean cage bottoms, and place the cage bottoms on a cart, rack, pallet, or fixture. Additionally, the present invention comprises an optical arranger robot with vision processing for detecting, and moving skewed cage bottoms to a re-grip station. From the re-grip station, the clean side robot places the cage bottoms on a rack, pallet, fixture, or any other device suitable for holding a plurality of cage bottoms.
Patent CA-2553830-A1 (CA)
Title: Reactor-regenerator device and use thereof in the production of styrene
Inventor: SANFILIPPO DOMENICO
IPC: B01J8/38
Filed: 2005-02-07
Abstract: Reactor-regenerator device, comprising at least one reactor for catalytic dehydrogenation reactions of hydrocarbons and at least one regenerator of the catalyst o the "fast riser" type wherein the regenerator-riser is a substan~tially tubular apparatus for chemical reactions which com~prise a gaseous phase in close contact with a solid phase, wherein gas phase and solid particles move upwards in co~current flow.
Patent CA-2556350-A1 (CA)
Title: Prodrugs of substituted amino heterobicycles which modulate the function of the vanilloid-1 receptor (vr1)
Inventor: HOLLINGWORTH GREGORY JOHN
IPC: C07D487/04
Filed: 2005-02-16
Abstract: Compounds of formula (I) which are useful as therapeutic compounds, particularly in the treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1).
Patent CA-2557218-A1 (CA)
Title: Bromine addition for the improved removal of mercury from flue gas
Inventor: DOWNS WILLIAM
IPC: B01J8/00
Filed: 2005-03-21
Abstract: Bromine-containing compounds (10), added to the coal (16), or to the boiler combustion furnace (14), are used to enhance the oxidation of mercury, thereby enhancing the overall removal of mercury in downstream pollution control devices. The method is applicable to utility power plants equipped with wet FGD systems, as well as those plants equipped with spray dryer absorber FGD  systems.